EDMONTON and HAMILTON, ON, Oct. 8, 2019 /CNW/ – PRESS RELEASE – Canadian Licensed Producer Aurora Hashish Inc. and CTT Pharmaceutical Holdings, Inc. have introduced the profitable commercialization of CTT’s cannabinoid-infused sublingual wafers. The brand new cannabis product line, a primary of its type, has been launched by Aurora within the Canadian medical cannabis market below the model title « Dissolve Strips. »
Aurora has an possession curiosity in CTT of roughly 9 p.c, with a warrant permitting it to extend its stake to 42.5 p.c, and entry to CTT’s sublingual wafers drug supply expertise, which is patent protected or patent pending in a number of jurisdictions.
« Aurora’s Dissolve Strips present distinctive benefits over different ingestible merchandise as a result of their ease of administration, discrete nature and correct dosage, that gives extra fast bioavailability of cannabinoids by way of sublingual use, » stated Terry Sales space, CEO of Aurora. « This provides yet one more progressive providing to our rising portfolio of top of the range, medical merchandise that we provide our affected person base, and is testomony to our trade main means to work with expertise companions and regulators to deliver new kind elements to market quickly. »
CTT’s CEO Cam Birge added, « The product launch with Aurora of the Dissolve Strips is a significant milestone for us that marks the transition of CTT from a expertise improvement section to a income producing section. That is the end result of years of onerous work by our founder Dr. Modi and your complete CTT and Aurora product improvement groups. We’re very pleased with this co-achievement and congratulate Aurora for the appreciable efforts and product enhancements to deliver Dissolve Strips to the cannabis market. Our sights, nonetheless, are set a lot increased. The following stage in our improvement would be the launch of a broader portfolio of distinctive merchandise on a worldwide scale. We’ve got been working in direction of this, and I look ahead to reporting on our progress within the coming quarters. »
Orally Dissolvable Skinny Movie (ODF) Wafers are a proprietary drug supply mechanism within the type of paper-thin polymer movies used as carriers for pharmaceutical brokers which have the next advantages:
- ODF Wafer is taken orally however doesn’t require water or swallowing.
- ODF Wafers dissolve shortly within the oral cavity (5-15 seconds), with the energetic ingredient quickly absorbed and subtle for direct entry to the bloodstream.
- The energetic ingredient, as soon as absorbed, can bypass the liver’s first-pass impact, enhancing therapeutic outcomes and efficacy by means of improved bioavailability, and facilitates wonderful affected person compliance.
- ODF Wafers are appropriate for a variety of sufferers, together with geriatric and pediatric sufferers who expertise problem swallowing.